𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes

✍ Scribed by List, A; Beran, M; DiPersio, J; Slack, J; Vey, N; Rosenfeld, C S; Greenberg, P

Book ID
110055554
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
202 KB
Volume
17
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination decitabine, arsenic trioxide
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study
✍ John S. Welch; Jeffery M. Klco; Feng Gao; Elizabeth Procknow; Geoffery L. Uy; Ke 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Childhood immune thrombocytopenia (ITP) has a favorable outcome in most cases but severe bleeding may occur, mostly in children with very low platelet counts. Although first-line therapies are well defined, management of refractory ITP is not consensual. Vinblastine (VBL) is one second-line treatmen